Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

被引:0
作者
K L Mahon
W Qu
J Devaney
C Paul
L Castillo
R J Wykes
M D Chatfield
M J Boyer
M R Stockler
G Marx
H Gurney
G Mallesara
P L Molloy
L G Horvath
S J Clark
机构
[1] Chris O’Brien Lifehouse,Cancer Research Division
[2] Garvan Institute of Medical Research/The Kinghorn Cancer Centre,undefined
[3] Sydney Medical School,undefined
[4] University of Sydney,undefined
[5] Royal Prince Alfred Hospital,undefined
[6] Menzies School of Health Research,undefined
[7] NHMRC Clinical Trials Centre,undefined
[8] University of Sydney,undefined
[9] Northern Haematology and Oncology Group,undefined
[10] SAN Clinic,undefined
[11] Westmead Hospital,undefined
[12] Calvary Mater Newcastle,undefined
[13] CSIRO Animal,undefined
[14] Food and Health Sciences,undefined
[15] St Vincent’s Clinical School,undefined
[16] University of NSW,undefined
来源
British Journal of Cancer | 2014年 / 111卷
关键词
castrate-resistant prostate cancer; chemotherapy; glutathione S-transferase 1; methylation; prognosis; therapeutic response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1802 / 1809
页数:7
相关论文
共 227 条
[31]  
Westra WB(undefined)undefined undefined undefined undefined-undefined
[32]  
Sidransky D(undefined)undefined undefined undefined undefined-undefined
[33]  
Danila DC(undefined)undefined undefined undefined undefined-undefined
[34]  
Fleisher M(undefined)undefined undefined undefined undefined-undefined
[35]  
Scher HI(undefined)undefined undefined undefined undefined-undefined
[36]  
Danila DC(undefined)undefined undefined undefined undefined-undefined
[37]  
Heller G(undefined)undefined undefined undefined undefined-undefined
[38]  
Gignac GA(undefined)undefined undefined undefined undefined-undefined
[39]  
Gonzalez-Espinoza R(undefined)undefined undefined undefined undefined-undefined
[40]  
Anand A(undefined)undefined undefined undefined undefined-undefined